Full coverage· Economy· Updated
Brainsway Reports 107% Surge in Operating Profit, Exceeds Q3 Expectations
Israeli medical technology firm Brainsway reported a 107% surge in third-quarter operating profit to $2.6 million on revenues of $18.1 million, a 34% increase. The company also saw a 44% rise in Deep TMS system deliveries and a 31% increase in its future order backlog, reaching $85 million.
2 newsrooms · 1 language · since
Plus
What happened
- 01Brainsway's Q3 operating profit soared 107% to $2.6 million on $18.1 million in revenue.
- 02The company delivered 130 Deep TMS systems, a 44% year-over-year increase.
- 03Future orders backlog reached $85 million, up 31% from the previous year.
- 04Clinical study shows Deep TMS reduced suicidal ideation by 70% in six weeks.
- 05Brainsway anticipates 2026 financial results will meet or exceed previous forecasts.
Brainsway highlighted positive clinical trial results for its Deep TMS technology in reducing suicidal ideation and treating depression in early-stage Alzheimer's patients, while noting FDA approval is pending for these uses. The company projects its 2026 financial performance to meet or exceed previous forecasts.
The coverage
2 newsrooms on this story
Who covered it
- LeftNone
- CentreNone
- RightNone
- HarediNone
- ArabNone
- Other2
How it broke
See which of the 2 newsrooms broke it, and who waited